Ozempic Maker Novo Rises After First Stock Split in a Decade
(Bloomberg) -- Novo Nordisk A/S shares fell on Wednesday in the first trading session following a split aimed at increasing the liquidity of the Danish drugmaker’s soaring stock.Most Read from BloombergLuxury Cruise Ship Full of Australians Stuck in Greenland ArcticiPhone Pro’s Titanium Finish Stands Out in First Look at DeviceChina Flags ‘Security Incidents’ With Apple’s iPhonesApple’s iPhone 15 Debut Includes Higher Price on Top ModelAT&T, T-Mobil...
United States Bloomberg Businessweek Nicolas Domont Michael Leuchten Bloomberg Novo Nordisk Thomas Brenier
Source: yahoo.com